Nexus Pharmaceuticals Receives Patent for EMERPHED®

Nexus Pharmaceuticals Receives Patent for EMERPHED®

LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Nexus Pharmaceuticals, Inc., a U.S.-based healthcare company and domestic pharmaceutical manufacturer, has received a patent covering applications of EMERPHED® Ready-To-Use Ephedrine Sulfate Injection, the first...
Parkside Athletics Announces Partnership with Nexus

Parkside Athletics Announces Partnership with Nexus

KENOSHA, Wis. — Parkside Athletics and Nexus Pharmaceuticals are thrilled to announce a multi-year partnership in support of RangerVision 2020, Director of Athletics Andrew Gavin announced today. The partnership is highlighted by the creation of The Nexus...